baber/WOPTO huggingface dataset:
Patent CA-2515290-A1 (CA)
Inventor: PELLED DORI
IPC: A23L1/30
Filed: 2004-02-10
Abstract: The present invention relates to the use of a composition comprising a combination of diacylglycerol(s) (DAG), mainly 1,3-diacylglycerol(s), and phytosterol and/or phytostanol ester(s) (PSE) dissolved or dispersed in edible oil and/or edible fat, particularly olive, canola and fish oil, in the manufacture of nutritional supplements and orally administrable pharmaceutical preparations which are capable of reducing blood levels of both cholesterol and triglycerides and/or for lowering serum, serum LDL and macrophage oxidation levels, inhibiting the formation of foam cells and/or preventing the deleterious effects generated by lipid-induced oxidative stress. In addition, the composition of the invention, as well as the pharmaceutical preparations thereof, is suitable for the treatment and prevention of conditions related to atherosclerosis, such as cardiovascular disease (CVD), coronary heart disease (CHD) and diabetes mellitus.
Patent CA-2517767-A1 (CA)
Title: Ligands that bind to the amyloid-.beta. precursor peptide and related molecules and uses thereof
Inventor: SUDHOF THOMAS C
IPC: C07K16/18
Filed: 2004-03-03
Abstract: The present invention provides a composition comprising an isolated F-spondin polypeptide specifically bound to an APP or APLP polypeptide. The present invention further provides a composition comprising an isolated neurexin polypeptide specifically bound to an APP or APLP polypeptide. Also provided are methods of screening for modulators of the binding of an APP or an APLP  polypeptide by F-spondin or neurexin proteins. Modulators of the binding of an APP or an APLP polypeptide by F-spondin or neurexin proteins may be useful in the treatment or prevention of AD.
Patent CA-2519410-A1 (CA)
Title: Pharmaceutical composition and procedure to treat and prevent prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits
Inventor: ARRUZAZABALA VALMANA MARIA DE
IPC: A61K36/00
Filed: 2004-03-15
Abstract: The invention relates to a novel pharmaceutical composition and to the method of producing same from the fruits of the royal palm (Roystonea regia) in order to prevent and/or treat benign prostatic hyperplasia (BPH) and prostatitis as well as alopecia and hirsutism. The inventive composition comprises a mixture of free fatty acids and/or the esters thereof, within a range of between 8 and 28 carbon atoms, in particular between 8 and 18 carbon atoms, and, more specifically, saturated straight-chain free fatty acids with 8, 10, 12, 14, 16 and 18 carbon atoms and mono-unsaturated free fatty acids with 16:1 and 18:1 carbon atoms. The inventive method of producing the aforementioned composition comprises the drying and crushing of the fruits, with optional basic hydrolysis, and, subsequently, selective extraction in organic solvents.
Patent CA-2520595-A1 (CA)
Title: Air circulating system for an isolation room, nurses station and the like
Inventor: CHRISTISON MICHAEL
IPC: F24F9/00
Filed: 2005-09-22
Abstract: A venting system to reduce the likelihood of a doctor, nurse or other healthcare worker contracting an infectious disease from a patient, and a method of operating the venting system, are provided.
Patent CA-2521330-A1 (CA)
Title: Calcium channel inhibitors comprising benzhydril spaced from piperazine
Inventor: BELARDETTI FRANCESCO
IPC: C07D295/08
Filed: 2004-04-08
Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
Patent CA-2521510-A1 (CA)
Inventor: SETHI ASEEM
IPC: H04L29/06
Filed: 2004-04-29
Abstract: A method for executing end to end authentication in a network environment is provided that includes initiating a communications tunnel with a layer two tunnel protocol (L2TP) network server (LNS) and communicating an activate context request that includes an authentication protocol in a protocol configuration option (PCO) field, the activate context request being received by a gateway general packet radio service (GPRS) support node (GGSN) that initiates a link control protocol (LCP) negotiation with the LNS, the GGSN  being operable to communicate an activate context response that may be received by the mobile terminal. An authentication response may be calculated by using a secret value and a challenge value which is provided by the GGSN, the authentication response being used to establish a communication session associated with the mobile terminal.
Patent CA-2523117-A1 (CA)
Title: Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions
Inventor: POTASH ROBERT T
IPC: C12N5/08
Filed: 2004-03-24
Abstract: The present invention provides compositions that may be useful, inter alia, in medical procedures, methods for making such compositions, and methods of performing medical procedures using such compositions. The present invention further provides a kit that includes a first container comprising a dispensing means and a first compound; and a second container comprising a dispensing means and a second compound, wherein the first compound may include, inter alia, a naturally occurring polyol, a biocompatible synthetic polyol, and mixtures thereof, and wherein the second compound may include, inter alia, isocyanate.
Patent CA-2526382-A1 (CA)
Inventor: ZUPKOFSKA MICHAEL E
IPC: A61F2/90
Filed: 2004-05-24
Abstract: An open frame prosthesis (16) is formed with looped end terminations (34, 36, 38) at its proximal and distal ends. At one end of the prosthesis, the filaments or strands are welded together in pairs to form strand couplings (46). A plurality of loop segments are connected to the strand couplings, one loop segment for each pair of adjacent strand couplings. In one version of the prosthesis, strands at the opposite end are bent to form looped ends (33). In another version, loop segments are connected to pairs of strand couplings at both ends of the prosthesis. The loop segments can be connected to the couplings by welding, fusion bonds, or tubes, which are either crimped or heat shrunk.
Patent CA-2527508-A1 (CA)
Inventor: FEITZ ANDREW
IPC: B01J37/03
Filed: 2004-05-26
Abstract: This invention describes, a process for producing a nanoscale zero-valent metal, including reduction of a metal ion solution with a dithionite compound, wherein the reduction is carried out under alkaline conditions under substantially an inert atmosphere. A nanoscale zero-valent metal obtainable by this process, and having a new crystalline form, is also described. The nanoscale zero-valent metal produced by the process of the invention is preferably iron, and is advantageously used for the remediation of contaminated water.
Patent CA-2533196-A1 (CA)
Inventor: HEIMERIKX JOS
IPC: A61K31/20
Filed: 2006-01-19
Abstract: Pinolenic acid or a derivative thereof can be used for weight management. The pinolenic acid may, for example, be used in the form of a food supplement, a pharmaceutical composition or a food composition.
Patent CA-2534051-A1 (CA)
Inventor: OZAKI MASAKO
IPC: A61B5/00
Filed: 2004-07-28
Abstract: There is provided an internationally effective dementia check system and the like for early discovery of the initial symptom of senile dementia. The system includes: an answer acquisition section (121) for acquiring answers made by an examinee within a predetermined answer limit time for a first test chart and a second test chart; and a dementia degree decision section (122) for deciding the dementia degree indicating the dementia degree of the examinee. The first test chart includes character groups constituting a story containing color words expressing colors and having test sentences in which respective color words are colored by identical colors, respectively, asking whether the color is identical to the color expressed by the color word. Whether the answer is correct or incorrect can be judged objectively. The second test chart includes a plurality of questions concerning the contents of the test sentences and a plurality of answers prepared for each of the questions from which only one correct answer is to be selected.
Patent CA-2534096-A1 (CA)
Title: 2-`4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
Inventor: TORRENS JOVER ANTONI
IPC: C07D405/12
Filed: 2004-07-29
Abstract: It was an object of the present invention to provide novel compounds that are suitable in particular as active substances in medicaments, preferably in medicaments for the regulation of neuropeptide Y receptors, particularly preferably of neuropeptide Y5 (NPY5) receptor, for the regulation of food ingestion (food intake), preferably for the prophylaxis and/or treatment of disorders of food ingestion, such as obesity., anorexia, cachexia, bulimia or type II (non insulin dependent) diabetes, for the prophylaxis and/or treatment of disorders of the peripheral nervous system, disorders of the central nervous system, anxiety, depression, cognitive disorders, preferably memory disorders, cardiovascular diseases, pain, epilepsy, arthritis, hypertensive syndrom, inflammatory diseases, immune diseases and other NPY5 mediated disorders in animals and mammals, including man. Said object was achieved by providing 1,4-disubstituted piperidine compounds of general formula (1) wherein the substituents are defined in claim 1.
Patent CA-2534445-A1 (CA)
Title: Agent for promoting hgf production comprising heparin-like oligosaccharides
Inventor: NAKAMURA TOSHIKAZU
IPC: A61K31/7016
Filed: 2005-03-28
Abstract: An HGF production accelerator containing as an active ingredient an oligosaccharide which is any of a 2-saccharide comprising a uronic acid residue (the uronic acid is iduronic acid or glucuronic acid; the same applies hereinafter) and a glucosamine residue bonded to the uronic acid residue through an .alpha.-1,4-glycoside bond or .beta.-1,4-glycoside bond, 3- to 16-saccharides each having a structure in which a uronic acid residue and a glucosamine residue have been alternatively bonded repeatedly through an .alpha.-1,4-glycoside bond or .beta.-1,4-glycoside bond, and salts of these, wherein at least one hydroxy group of the uronic acid residue(s) and glucosamine residue(s) may have been sulfated, alkylated, acylated, or aminated and the 2-position amino group of at least one glucosamine residue may have been sulfated, alkylated, or acylated. The HGF production accelerator is useful for accelerating the treatment of disorders of tissues, organs, etc.  of the living body.
Patent CA-2539006-A1 (CA)
Title: Stretch wrap apparatus
Inventor: SOLIS ALFONSO
IPC: B65B51/04
Filed: 2004-08-31
Abstract: The instant invention comprises an apparatus and method for wrapping a load under tension with a web of stretch wrap flexible material and then binding the wrapping material to the load by compressing the end of the flexible material into a rope-like configuration. The rope formed is wound around the load at least one turn. A second turn of the rope around the load is then bound to the first rope with a mechanical twisting tie around the two ropes to prevent unwrapping of the load during transit and storage. A hot wire cutting mechanism cuts the rope and the bound two ropes snap back into position against the wrapped load from the force of the stretch wrap tension.
Patent CA-2539652-A1 (CA)
Inventor: OGONOWSKI KAZIMIERZ
IPC: G06Q30/02
Filed: 2006-03-15
Abstract: A method for determining a secondary value having a second--highest priority in a list of values in a spreadsheet is provided. A primary value having a highest priority in the list of values is determined. The secondary value is determined to be equal to the primary value if more than one of the values in the list is equal to the primary value. The secondary value is determined to be equal to one of the list of values not equal to the primary value having a relative highest priority if only one of the values in the li st is equal to the primary value.
Patent CA-2540615-A1 (CA)
Title: Method and apparatus for real-time signal analysis
Inventor: NIKITIN ALEXEL V
IPC: G06G7/18
Filed: 2004-09-30
Abstract: An apparatus for signal processing operable to transform an input signal into an output signal comprising a Threshold Domain Filtering module operable to perform Threshold Domain Filtering and at least one additional module operable to perform a function selected from the group consisting of Multimodal pulse Shaping, Analog Rank Filtering, and Analog Counting.
Patent CA-2542356-A1 (CA)
Title: Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds
Inventor: DAHMS WOLFGANG
IPC: C25D3/38
Filed: 2004-11-09
Abstract: For manufacturing particularly uniform and mirror bright copper coatings that are leveled and ductile as well using a relatively high current density, halogenated or pseudohalogenated monomeric pheanzinium compounds or a purity at least 85 mole-% and having the general chemical formula (I) are utilized in which R1, R2, R3, R4. R5, R6, R7, R7~~, R8, R9, X and A.macr.have the significations denoted in the claims. The compounds are prepared by diazotizing a suited starting compound prior to halogenating or pseudohalogenating it in the presence of mineral acid, diazotization means and halide or pseudohalide, with the reaction steps being run in one single vessel.
Patent CA-2543046-A1 (CA)
Title: Drip tray tablet
Inventor: KRITZLER STEVEN
IPC: A01N63/50
Filed: 2004-10-20
Abstract: A tablet for use in a drip tray including an excipient selected so that the tablet will not fully dissolve in water at ambient temperature for a period of at least one month, more preferably up to 12 months, a biocide, at least one enzyme, preferably a proteolytic or hydrolase enzyme, and enzyme preserving means, such as a boron compound for maintaining enzyme activity in a moist environment. The excipient may be for example poly vinyl alcohols, high molecular weight polyethylene glycols, high molecular weight polypropylene glycols, esters or partial esters of polyethylene glycols or of polypropylene glycols, and high molecular weight thermoplastic surfactants. The invention also relates to methods for inhibiting the growth of biofilm in an drip tray or the like, including the step of adding to the tray a tablet according to the invention.
Patent CA-2544088-A1 (CA)
Title: Shaft coupling for barrier movement operators
Inventor: OLMSTED ROBERT J
IPC: E05D15/24
Filed: 2006-04-19
Abstract: A barrier movement or garage door operator has a jack shaft connected to an output shaft delivering power to move a barrier or garage door between open and closed positions, the jack shaft and output shaft being connected by a coupling. The coupling, jack shaft, and output shaft are fixed relative to each other. The coupling connects the jack shaft and output shaft for rotation around a common axis.  The coupling receives a portion of the jack shaft and output shaft for securing the shafts within the coupling by compressing against an outer surface of each shaft. The shafts may be cylindrical, and the compressive force may be distributed around the cylindrical outer surface of the shafts. The coupling may have a portion sized to correspond to respective predetermined diameters or sizes of the shafts.
Patent CA-2545150-A1 (CA)
Title: Method and apparatus for adaptive echo and noise control
Inventor: PAN JIANHUA
IPC: G10L21/0208
Filed: 2004-11-17
Abstract: An method (500) and apparatus (100) for adaptive echo and noise control. A  signal can be received at an input (140) to a communication or electronic device. Background noise in the signal can be determined. The order of noise suppression and echo cancellation can be adaptively determined (110) based on the background noise in the signal. Adaptively determining the order of noise suppression (230) and echo cancellation (220) can be performed by comparing the background noise to at least one threshold, performing echo cancellation prior to noise suppression on the signal if the background noise is below the at least one threshold, and performing noise suppression prior to echo cancellation on the signal if the background noise is above the at least one threshold.
Patent CA-2545259-A1 (CA)
Title: Heteroaryl-hydrazone compounds
Inventor: ONO MITSUNORI
IPC: C07D251/16
Filed: 2004-11-10
Abstract: This invention relates to compounds having a formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, hydrate, prodrug or polymorph thereof wherein X is -C(Rg)=N-A. The invention also relates to methods of treating IL-12 verproduction-related disorders, methods of treating or preventing disorders related with excessive bone loss, methods for inhibiting osteoclast formation, and methods for treating or preventing a disorder associated with excessive bone resorption.
Patent CA-2546012-A1 (CA)
Title: Lockable container with integral internal tray
Inventor: HESSION CHRISTOPHER
IPC: B65D5/38
Filed: 2004-11-19
Abstract: A method of resisting access to an item, comprising the steps of: providing a slide card comprising a base panel and attached extension panel comprising at least one securing section, a pair of sidewall sections, and a top section all separated by adjacent fold lines; providing a first engaging element associated with said card; providing an outer sleeve that defines a void with an open end configured to receive said inner slide card with tray; providing a second engaging element associated said sleeve; affixing said securing section to said base panel such that said sidewall sections are substantially parallel; providing at least one receiving aperture in one of said sidewall panels; placing an item in said receiving aperture; aligning said card with said open end; orienting said first engaging element with said second engagement element; inserting said card and tray fully into said void; and causing said first engaging element to releasably lock said second engaging element
Patent CA-2547158-A1 (CA)
Title: Gauss-rees parametric ultrawideband system
Inventor: REES FRANK L
IPC: G01V1/00
Filed: 2004-11-24
Abstract: Gauss-Rees waveform utilization in identifying an object, including: directing a primary acoustic waveform at the object to produce a nonlinear acoustic effect; receiving a secondary wavelet produced by the nonlinear effect; and processing the received secondary wavelet in identifying the object. The object is identified by composition, image, and preferably both. The object can be concealed in a container, underground, under water, or otherwise.
Patent CA-2548015-A1 (CA)
Inventor: SCHREIBER JOHN R
IPC: A61K39/40
Filed: 2004-12-03
Abstract: The invention described herein provides for human antibodies produced in non-human animals that specifically bind to lipopolysaccharide (LPS) from strains Fisher Devlin (International Serogroups) It-2 (011), It-3 (02), It-4 (01), It-5 (010), It-6 (07), PA01 (05), 170003 (02), IATS016 (02/05), and 170006 (02).  The invention further provides methods for making the antibodies in a non-human animal, expression of the antibodies in cell lines including hybridomas and recombinant host cell systems. Also provided are kits and pharmaceutical compositions comprising the antibodies and methods of treating or preventing pseudomonas infection by administering to a patient the pharmaceutical compositions described herein.
Patent CA-2548770-A1 (CA)
Title: A medical solution, a method for producing said medical solution and use thereof
Inventor: WIESLANDER ANDERS
IPC: A61K/
Filed: 2005-02-22
Abstract: The present invention relates to a medical solution comprising a first single solution containing glucose and/or glucose-like compound. According to the present invention said first single solution has a pH in the range of 1.8-2.6.  The present invention further relates to a method for producing said medical solution as well as use thereof.
Patent CA-2551556-A1 (CA)
Inventor: MASTENBROEK MARTIN
IPC: A62B35/04
Filed: 2004-12-14
Abstract: A safety device for a fall restraint comprises an anchoring member (1) to which the fall restraint can be coupled directly or indirectly, and fastening means for a firm and durable connection to an object (10). The fastening means are formed by a flexible fastening flap (11) which extends laterally from the device and which is intended and adapted to bring about said firm and durable connection to the object.
Patent CA-2552293-A1 (CA)
Title: Computer system for database administration and graphical user interface for same
Inventor: MITCHELL WILLIAM G
IPC: G06Q10/00
Filed: 2006-07-12
Abstract: An apparatus comprises a database administration interface and a graphical user interface configured to receive information regarding an organization, an organization evaluation, and an evaluation of the organization evaluation. The apparatus further comprises a database including a database schema configured to store information relating to the organization that is received by the database administration interface. The apparatus further comprises an organization evaluation module configured to assign a composite performance designation to the organization based on information relating to the organization that is stored in the database. The composite performance designation is stored in the database. The apparatus further comprises a plurality of distributed client interfaces configured to access and controllably display information stored in the database relating to the organization.
Patent CA-2552488-A1 (CA)
Inventor: ARAI KEIICHIROU
IPC: H01L21/47
Filed: 2004-08-27
Abstract: A process for producing a film of organic material excelling in moisture barrier property and/or oxygen barrier property; and an electronic device avoiding performance deterioration by air moisture and oxygen and excelling in long-term stability, which electronic device is obtained by incorporating the film produced by the above process in an electronic device, especially using the film as a protective film in an organoelectronic device. The process is characterized in that a liquid crystal polymer exhibiting optical anisotropy is irradiated with pulsed laser so as to effect evaporation formation into a vaporization product, and that the vaporization product is deposited on a substrate and solidified.
Patent CA-2553711-A1 (CA)
Inventor: KINOSHITA SHIGERU
IPC: A61P27/02
Filed: 2005-01-11
Abstract: A new application of the dacryogenic component of onions and an analogue of the component in the medicinal field. It is a reagent for lacrimation examination which contains as an active ingredient a compound represented by the following chemical formula: [Chemical formula 10] (I) wherein R represents a C1-5 alkyl chain.
Patent CA-2554503-A1 (CA)
Title: Lead screw driven syringe with an integral split plunger nut and method of using the same
Inventor: STUTZ WILLIAM H JR
IPC: A61M5/145
Filed: 2004-03-19
Abstract: An improved reservoir is provided for use in a medication infusion device for operating the reservoir to administer a fluid to a patient. The reservoir comprises a hollow barrel adapted to received a supply of fluid for delivery through infusion tubing or the like to the patient, in combination with a reservoir plunger. The reservoir plunger is designed to engage a motor-driven lead screw of the medication infusion device. The reservoir plunger has an integral split nut connector formed on the end of the plunger, which is in co-axial alignment with the lead screw whereby the split nut connector can be engaged directly to the lead screw.